July 2005
757
cording to the method of Ishii et al.51)
(5.0 mmol) in concentrated hydrochloric acid (10 ml) containing acetic acid
(5 ml) was refluxed for 2 h. The mixture was poured into ice-water (100 ml),
and then the resulting precipitate was collected, washed with water, and re-
crystallized from ethanol to give 3a as yellow needles. 1H-NMR (DMSO-d6,
ppm) d: 3.82 (3H, s, C6-OCH3), 7.33 (1H, d), 7.40 (1H, d), 7.48 (1H, s),
8.70 (1H, s), 13.25 (1H, broads, C3-COOH). HR-MS (EIꢄ) m/z: 220.0365
(Calcd for C11H8O5: 220.0372).
3-Formyl-6,7-benzocoumarin (6e): A solution of 6d (1.5 mmol) dissolved
in toluene was refluxed with selenium dioxide (2.0 mmol) for 2 h. The mix-
ture was filtered hot to remove black selenium, and the filtrate was concen-
trated under reduced pressure. The residue was purified by column chro-
matography on silica gel eluted with chloroform–ethyl acetate (7 : 3), and the
1
desired fractions were concentrated to give 6e as yellow crystals. H-NMR
General Synthetic Method of Derivatized Products 3b—f To an ice-
cold suspension of 3a (1.0 mmol), 1-ethyl-3-(3-dimethylaminopropyl)car-
bodiimide hydrochloride (EDC HCl) (1.1 mmol), N,N-dimethylaminopyri-
dine (DMAP) (1.1 mmol) in dichloromethane (20 ml) was added dropwise to
the appropriate alcohols, phenols, or amines with stirring. The reaction mix-
ture was stirred for a further 1 h at room temperature, and then the mixture
was washed with saturated aqueous NaHCO3 and water. The solution was
dried over anhydrous Na2SO4 and the solvent was evaporated. The residue
was purified by column chromatography on silica gel eluted with ethyl ac-
etate. Recrystallization from ethanol gave 3b—f as pale yellow needles in
62—92% yield.
(CDCl3, ppm) d: 7.56 (1H, t), 7.67 (1H, t), 7.77 (1H, s), 7.91 (1H, d), 7.98
(1H, d), 8.26 (1H, d), 8.56 (1H, s), 10.36 (1H, s, C3-CHO). HR-MS (EIꢄ)
m/z: 224.0475 (Calcd for C14H8O3: 224.0474).
6,7-Benzocoumarin (6f): This compound was synthesized in a similar
manner to that described for 1b and purified by recrystallization from
ethanol–chloroform to give the product as yellow needles.
3-Bromoacetyl-6,7-benzocoumarin (6g): This compound was synthesized
from acetyl compound 6b in a similar manner to that described for 2a and
purified by recrystallization from ethanol–chloroform to give the product as
yellow needles. 1H-NMR (CDCl3, ppm) d: 4.80 (2H, s, C3-COCH2Br), 7.56
(1H, t), 7.67 (1H, t), 7.77 (1H, s), 7.92 (1H, d), 7.99 (1H, d), 8.27(1H, s),
8.78 (1H, s). HR-MS (EIꢄ) m/z: 315.9734 (Calcd for C15H9O3Br: 315.9735).
General Synthetic Method of Derivatized Products 6h—j These
compounds were synthesized from 6g in a similar manner to that described
for 2b—d and purified by column chromatography on silica gel eluted with
chloroform–ethyl acetate (9 : 1). Recrystallization from ethanol–chloroform
gave 6h—j as pale yellow needles in 60—92% yields.
1
Methyl 6-Methoxycoumarin-3-carboxylate (3b): H-NMR (CDCl3, ppm)
d: 3.87 (3H, s, C6-OCH3), 3.96 (3H, s, COOCH3), 7.03 (1H, s, C5-H), 7.24
(1H, d, C7-H), 7.31 (1H, d, C8-H), 8.53 (1H, s, C4-H). HR-MS (EIꢄ) m/z:
234.0521 (Calcd for C12H10O5: 234.0528).
1
Phenyl 6-Methoxycoumarin-3-carboxylate (3c): H-NMR (CDCl3, ppm)
d: 3.88 (3H, s, C6-OCH3), 7.06 (1H, s, C5-H), 7.24—7.30 (4H, m, C7-H, Ar-
H), 7.34 (1H, d, C8-H), 7.44 (2H, t, Ar-H), 8.69 (1H, s, C4-H). HR-MS (EIꢄ)
m/z: 296.0690 (Calcd for C17H12O5: 296.0685).
6,7-Benzocoumarin-3-carbonylmethyl acetate (6h): 1H-NMR (CDCl3,
ppm) d: 2.24 (3H, s, –CH3), 5.42 (2H, s, –COCH2–), 7.54—8.25 (6H, m),
8.77 (1H, s). HR-MS (EIꢄ) m/z: 296.0694 (Calcd for C17H12O5: 296.0685).
6,7-Benzocoumarin-3-carbonylmethyl Laurate (6i): 1H-NMR (CDCl3,
ppm) d: 0.89 (3H, t, –CH3), 1.25—1.39 (16H, m), 1.72 (2H, m), 2.49 (2H,
t), 5.42 (2H, s, –COCH2–), 7.56 (1H, t), 7.67 (2H, t), 7.77 (1H, s), 7.92 (1H,
d), 7.98 (1H, d), 8.25 (1H, s), 8.77 (1H, s). HR-MS (EIꢄ) m/z: 436.2242
(Calcd for C27H32O5: 436.2250).
6-Methoxycoumarin-3-N-methylcarboxamide (3d): 1H-NMR (CDCl3,
ppm) d: 3.03 (3H, d, NHCH3), 3.88 (3H, s, C6-OCH3), 7.08 (1H, s, C5-H),
7.23 (1H, d, C7-H), 7.34 (1H, d, C8-H), 8.88 (1H, s, C4-H). HR-MS (EIꢄ)
m/z: 233.0682 (Calcd for C12H11NO4: 233.0688).
6-Methoxycoumarin-3-N,N-dimethylcarboxamide (3e): 1H-NMR
(DMSO-d6, ppm) d: 3.02 (3H, s, N-CH3), 3.13 (3H, s, N-CH3), 3.86 (3H, s,
C6-OCH3), 6.94 (1H, s, C5-H), 7.13 (1H, d, C7-H), 7.30 (1H, d, C8-H), 7.86
(1H, s, C4-H). HR-MS (EIꢄ) m/z: 247.0843 (Calcd for C13H13NO4:
247.0845).
6,7-Benzocoumarin-3-carbonylmethyl Benzoate (6j): 1H-NMR (CDCl3,
ppm) d: 5.67 (2H, s, –COCH2–), 7.49 (2H, t), 7.55—7.69 (3H, m), 7.78 (1H,
s), 7.92 (1H, d), 7.98 (1H, d), 8.27 (1H, s), 8.15 (2H, d), 8.26 (1H, s), 8.79
(1H, s). HR-MS (EIꢄ) m/z: 358.0842 (Calcd for C22H14O5: 358.0841).
6-Methoxycoumarin-3-N-phenylcarboxamide (3f): 1H-NMR (DMSO-d6,
ppm) d: 3.90 (3H, s, C6-OCH3), 7.12 (1H, s, C5-H), 7.17 (1H, t, Ar-H), 7.28
(1H, m, C7-H), 7.37—7.40 (3H, m, C8-H, Ar-H), 7.75 (2H, d, Ar-H), 8.98
(1H, s, C4-H), 10.90 (1H, s, NH). HR-MS (EIꢄ) m/z: 295.0848 (Calcd for
C17H13NO4: 295.0845).
6,7-Benzocoumarin-3-carbonylchloride (6l):
A
suspension of 6a
(10 mmol) in concentrated hydrochloric acid (50 ml) containing acetic acid
(10 ml) was refluxed for 2 h. The mixture was poured into ice-water
(500 ml), and then the resulting precipitate was collected, washed with water,
and recrystallized from ethanol to give 6k as yellow needles. 1H-NMR
(DMSO-d6, ppm) d: 7.58 (1H, t), 7.69 (1H, t), 7.92 (1H, s), 8.04 (1H, d),
8.08 (1H, d), 8.56 (1H, s), 8.84 (1H, s), 13.32 (1H, broads, C3-COOH). HR-
MS (EIꢄ) m/z: 240.0432 (Calcd for C14H8O4: 240.0423). A suspension of 6k
(5.0 mmol) in thionyl chloride (15 ml) was refluxed for 12 h. After cooling,
excess thionyl chloride was evaporated to afford a crude product. This was
purified by recrystallization from benzene–petroleum ether to give pale yel-
low needles. 1H-NMR (CDCl3, ppm) d: 7.59 (1H, t), 7.71 (1H, t), 7.76 (1H,
s), 7.93 (1H, d), 8.01 (1H, d), 8.32 (1H, s), 9.00 (1H, s). HR-MS (EIꢄ) m/z:
258.0087 (Calcd for C14H7O3Cl: 258.0084).
General Synthetic Method of 4a and b, 5a and b, and 6a—c A mix-
ture of the hydroxynaphtaldehyde, 2-hydroxy-1-naphtaldehyde for 4a and b,
1-hydroxy-2-naphtaldehyde for 5a and b, and 2-hydroxy-3-naphtaldehyde50)
for 6a—c (10 mmol) and the appropriate ester (10 mmol) in 25 ml of ab-
solute ethanol was refluxed in the presence of a few drops of piperidine for
30 min. After cooling, the resulting precipitates were recrystallized from
ethanol to give benzocoumarins as yellow needles.
1
Ethyl 5,6-Benzocoumarin-3-carboxylate (4a): H-NMR (CDCl3, ppm) d:
1.46 (3H, t, –CH3), 4.49 (2H, q, –CH2–), 7.49 (1H, d), 7.63 (1H, t), 7.77
(1H, t), 7.95 (1H, d), 8.11 (1H, d), 8.35 (1H, d), 9.35 (1H, s). HR-MS (EIꢄ)
m/z: 268.0739 (Calcd for C16H12O4: 268.0736).
General Synthetic Method of Derivatized Products 6m—q To an ice-
cold solution of the appropriate alcohol, phenol, or amine (1.0 mmol) and
triethylamine (TEA) (1.1 mmol) in dichloromethane (20 ml) was added
dropwise 6l in dichloromethane (5 ml) with stirring. The reaction mixture
was stirred for a further 1 h at room temperature, and then the mixture was
washed with saturated aqueous NaHCO3 and water. The solution was dried
over anhydrous Na2SO4 and the solvent was evaporated. The residue was pu-
rified by recrystallization from ethanol to give 6m—q as pale yellow needles
in 60—70% yield.
3-Acetyl-5,6-benzocoumarin (4b): 1H-NMR (CDCl3, ppm) d: 2.80 (3H, s,
C3-COCH3), 7.50 (1H, d), 7.63 (1H, t), 7.77 (1H, t), 7.94 (1H, d), 8.12 (1H,
d), 8.39 (1H, d), 9.35 (1H, s). HR-MS (EIꢄ) m/z: 238.0639 (Calcd for
C15H10O3: 238.0630).
1
Ethyl 7,8-Benzocoumarin-3-carboxylate (5a): H-NMR (CDCl3, ppm) d:
1.44 (3H, t, –CH3), 4.45 (2H, q, –CH2–), 7.54 (1H, d), 7.68—7.73 (3H, m),
7.77 (1H, t), 7.90 (1H, d), 8.60 (1H, d), 8.35 (1H, d), 8.68 (1H, s). HR-MS
(EIꢄ) m/z: 268.0724 (Calcd for C16H12O4: 268.0736).
3-Acetyl-7,8-benzocoumarin (5b): 1H-NMR (CDCl3, ppm) d: 2.79 (3H, s,
C3-COCH3), 7.58 (1H, d), 7.70—7.74 (3H, m), 7.91 (1H, d), 8.60 (1H, d),
8.67 (1H, s). HR-MS (EIꢄ) m/z: 238.0620 (Calcd for C15H10O3: 238.0630).
1
Methyl 6,7-Benzocoumarin-3-carboxylate (6m): H-NMR (CDCl3, ppm)
d: 3.99 (3H, s, –COOCH3), 7.54 (1H, t), 7.64 (1H, t), 7.73 (1H, s), 7.90 (1H,
d), 7.96 (1H, d), 8.17 (1H, s), 8.70 (1H, s). HR-MS (EIꢄ) m/z: 254.0589
(Calcd for C15H14O4: 254.0579).
1
Ethyl 6,7-Benzocoumarin-3-carboxylate (6a): H-NMR (CDCl3, ppm) d:
Phenyl 6,7-Benzocoumarin-3-carboxylate (6n): 1H-NMR (CDCl3, ppm)
d: 7.28—7.32 (3H, m), 7.45 (2H, t), 7.56 (1H, t), 7.67 (1H, t), 7.78 (1H, s),
7.93 (1H, d), 7.99 (1H, d), 8.24 (1H, s), 8.87 (1H, s). HR-MS (EIꢄ) m/z:
316.0733 (Calcd for C20H12O4: 316.0736).
1.44 (3H, t, –CH3), 4.44 (2H, q, –CH2–), 7.54 (1H, d), 7.64 (1H, t), 7.73
(1H, s), 7.90 (1H, d), 7.96 (1H, d), 8.17 (1H, s), 8.66 (1H, s). HR-MS (EIꢄ)
m/z: 268.0746 (Calcd for C16H12O4: 268.0736).
3-Acetyl-6,7-benzocoumarin (6b): 1H-NMR (CDCl3, ppm) d: 2.77 (3H, s,
C3-COCH3), 7.55 (1H, d), 7.65 (1H, t), 7.75 (1H, s), 7.90 (1H, d), 7.97 (1H,
d), 8.22 (1H, s), 8.65 (1H, s). HR-MS (EIꢄ) m/z: 238.0620 (Calcd for
C15H10O3: 238.0630).
6,7-Benzocoumarin-3-N-methylcarboxamide (6o): 1H-NMR (CDCl3,
ppm) d: 3.05 (3H, d, –NHCH3), 7.56 (1H, t), 7.65 (1H, t), 7.78 (1H, s), 7.92
(1H, d), 7.99 (1H, d), 8.25 (1H, s), 8.78 (1H, s, –NH–), 9.06 (1H, s). HR-MS
(EIꢄ) m/z: 253.0740 (Calcd for C11H13NO3: 253.0739).
3-Cyano-6,7-benzocoumarin (6c): 1H-NMR (CDCl3, ppm) d: 7.59 (1H, t),
7.70 (1H, s), 7.81 (1H, s), 7.93 (1H, d), 7.99 (1H, d), 8.16 (1H, s), 8.39 (1H,
s). HR-MS (EIꢄ) m/z: 221.0479 (Calcd for C14H7NO2: 221.0477).
3-Methyl-6,7-benzocoumarin (6d): This compound was synthesized ac-
1
6,7-Benzocoumarin-3-N,N-dimethylcarboxamide (6p): H-NMR (CDCl3,
ppm) d: 3.05 (3H, s, N–CH3), 3.15 (3H, s, N–CH3), 7.53 (1H, t), 7.62 (1H,
t), 7.75 (1H, s), 7.90 (1H, d), 7.95 (1H, d), 8.04 (1H, s), 8.07 (1H, s). HR-